H. Stirnadel-Farrant

First name

H.

Middle name

A.

Last name

Stirnadel-Farrant

Rabe, A. P. J., Loke, W. J., Kalyani, R. N., Tummala, R., Stirnadel-Farrant, H. A., Were, J., & Winthrop, K. L. (2023). Impact of SARS-CoV-2 infection on patients with systemic lupus erythematosus in England prior to vaccination: a retrospective observational cohort study. Bmj Open, 13, e071072. http://doi.org/10.1136/bmjopen-2022-071072

View

Stirnadel-Farrant, H. A., Golam, S. M., Naisbett-Groet, B., Gibson, D., Langham, J., Langham, S., & Samnaliev, M. (2023). Healthcare Resource Use and Costs Associated with Organ Damage in Newly Diagnosed Adults with Systemic Lupus Erythematosus in the UK. Rheumatol Ther. http://doi.org/10.1007/s40744-023-00567-9

View

Stirnadel-Farrant, H. A., Golam, S. M., Naisbett-Groet, B., Gibson, D., Langham, J., Langham, S., & Samnaliev, M. (2023). Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK. Rheumatol Ther. http://doi.org/10.1007/s40744-023-00566-w

View

Wilkinson, S., Douglas, I. J., Williamson, E., Stirnadel-Farrant, H. A., Fogarty, D., Pokrajac, A., et al. (2018). Factors associated with choice of intensification treatment for type 2 diabetes after metformin monotherapy: a cohort study in UK primary care. Clin Epidemiol. http://doi.org/10.2147/clep.s176142

View